Aehr Test Systems [AEHR] vs Lam Research [LRCX] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Aehr Test Systems wins in 5 metrics, Lam Research Corporation wins in 14 metrics, with 0 ties. Lam Research Corporation appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Aehr Test Systems Lam Research Corporation Better
P/E Ratio (TTM) 19.85 54.64 Aehr Test Systems
Price-to-Book Ratio 21.30 32.75 Aehr Test Systems
Debt-to-Equity Ratio 7.22 44.20 Aehr Test Systems
PEG Ratio 0.05 1.49 Aehr Test Systems
EV/EBITDA -249.60 43.71 Lam Research Corporation
Profit Margin (TTM) -25.23% 30.22% Lam Research Corporation
Operating Margin (TTM) -41.01% 33.87% Lam Research Corporation
EBITDA Margin (TTM) N/A 33.87% N/A
Return on Equity -8.68% 65.57% Lam Research Corporation
Return on Assets (TTM) -6.10% 21.05% Lam Research Corporation
Free Cash Flow (TTM) $-12.39M $5.41B Lam Research Corporation
Dividend Yield N/A 0.55% N/A
1-Year Return 858.22% 309.75% Aehr Test Systems
Price-to-Sales Ratio (TTM) 66.38 16.22 Lam Research Corporation
Enterprise Value $2.98B $320.95B Lam Research Corporation
EV/Revenue Ratio 65.79 15.61 Lam Research Corporation
Gross Profit Margin (TTM) 32.66% 49.60% Lam Research Corporation
Revenue per Share (TTM) $2 $16 Lam Research Corporation
Earnings per Share (Diluted) $-0.38 $4.86 Lam Research Corporation
Beta (Stock Volatility) 2.29 1.79 Lam Research Corporation
Short % of Float 13.96% 2.50% Lam Research Corporation

Aehr Test Systems vs Lam Research Corporation Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Aehr Test Systems-3.75%11.63%-14.87%-3.36%178.87%265.70%
Lam Research Corporation6.03%19.87%36.60%77.27%136.71%110.16%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Aehr Test Systems858.22%175.30%4,345.49%6,098.29%8,577.60%1,070.12%
Lam Research Corporation309.75%498.78%498.68%4,324.73%8,551.18%8,033.26%

Performance & Financial Health Analysis: Aehr Test Systems vs Lam Research Corporation

MetricAEHRLRCX
Market Information
Market Cap i$3.02B$324.76B
Market Cap CategoryMid capMega cap
10 Day Avg. Volume i4,133,0968,724,462
90 Day Avg. Volume i3,379,2499,726,287
Last Close$81.04$388.92
52 Week Range$14.72 - $126.62$87.75 - $393.07
% from 52W High-36.00%-1.06%
All-Time High$126.62 (Jun 15, 2026)$393.07 (Jun 15, 2026)
% from All-Time High-36.00%-1.06%
Growth Metrics
Quarterly Revenue Growth-0.44%0.22%
Quarterly Earnings Growth-0.44%0.34%
Financial Health
Profit Margin (TTM) i-0.25%0.30%
Operating Margin (TTM) i-0.41%0.34%
Return on Equity (TTM) i-0.09%0.66%
Debt to Equity (MRQ) i7.2244.20
Cash & Liquidity
Book Value per Share (MRQ)$4.48$8.11
Cash per Share (MRQ)$1.17$4.95
Operating Cash Flow (TTM) i$-7,444,000$7.12B
Levered Free Cash Flow (TTM) i$-7,451,625$4.82B
Dividends
Last 12-Month Dividend Yield iN/A0.55%
Last 12-Month Dividend iN/A$1.24

Valuation & Enterprise Metrics Analysis: Aehr Test Systems vs Lam Research Corporation

MetricAEHR (Apr 26, 2026)LRCX (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i19.8554.64
Forward P/E i636.7337.12
PEG Ratio i0.051.49
Price to Sales (TTM) i66.3816.22
Price to Book (MRQ) i21.3032.75
Market Capitalization
Market Capitalization i$3.02B$324.76B
Enterprise Value i$2.98B$320.95B
Enterprise Value Metrics
Enterprise to Revenue i65.7915.61
Enterprise to EBITDA i-249.6043.71
Risk & Other Metrics
Beta i2.291.79
Book Value per Share (MRQ) i$4.48$8.11

Financial Statements Comparison: Aehr Test Systems vs Lam Research Corporation

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAEHR (2025)LRCX (2025)
Revenue/Sales i58.97M18.44B
Cost of Goods Sold i35.04M9.46B
COGS % of Revenue i59.4%51.3%
Gross Profit i23.93M8.98B
Gross Margin i40.6%48.7%
Research & Development i10.46M2.10B
Operating Income (EBIT) i-4.81M5.90B
Operating Margin i-8.2%32.0%
EBITDA i-561,0006.55B
EBITDA Margin i-1.0%35.5%
Pre-Tax Income i-4.29M5.96B
Pre-Tax Income % of Revenue i-7.3%32.3%
Income Tax i-381,000599.91M
Income Tax % of Revenue i-0.6%3.3%
Net Income (Profit) i-3.91M5.36B
Profit Margin i-6.6%29.1%

Balance Sheet & Liquidity Metrics

MetricAEHR (2025)LRCX (2025)
Cash & Equivalents i24.33M6.39B
Total Current Assets i88.78M14.52B
Total Current Assets % of Revenue i150.6%78.7%
Total Current Liabilities i15.64M6.57B
Total Current Liabilities % of Revenue i26.5%35.6%
Long-Term Debt i9.92M3.73B
Long-Term Debt % of Revenue i16.8%20.2%
Total Shareholders Equity i122.87M9.86B
Retained Earnings i-23.06M28.99B
Retained Earnings % of Revenue i-39.1%157.2%
Property, Plant & Equipment i12.50M23.22M

Cash Flow Statement Comparison

MetricAEHR (2025)LRCX (2025)
Operating Cash Flow i-2.53M6.05B
Operating Cash Flow % of Revenue i-4.3%32.8%
Capital Expenditures i-4.99MN/A
Free Cash Flow i-12.39M5.41B
FCF Margin i-21.0%29.4%
Debt Repayment iN/A-507.49M
Common Stock Repurchase iN/A-3.42B

Short Interest & Institutional Ownership Analysis

MetricAEHRLRCX
Shares Short i4.09M27.97M
Short Ratio i2.422.68
Short % of Float i13.96%2.50%
Shares Outstanding i30.95M1.25B
Float Shares i29.55M1.24B
% Held by Insiders i4.60%0.29%
% Held by Institutions i69.14%89.09%
% Held by Public i26.26%10.62%

Dividend Analysis & Yield Comparison: Aehr Test Systems vs Lam Research Corporation

MetricAEHRLRCX
Last 12-Month Dividend iN/A$1.24
Last 12-Month Dividend Yield iN/A0.55%
3-Year Avg Annual Dividend iN/A$0.95
3-Year Avg Dividend Yield iN/A0.25%
3-Year Total Dividends iN/A$2.84
Ex-Dividend DateN/AMar 04, 2026